MELI
MELI

The stocks of MELI have been given the brokerage rating of buy, from around 18 different brokerages that had been covering this company. According to a rating from Marketbeat, three of the analysts covering the firm gave it a rating of hold, while thirteen other research analysts gave the company a rating of buy. Currently, the company enjoys a price target of about $1,498.81, calculated over the entire year.

There have been quite a few brokerages that have commented on the stocks of MELI. Barclays has already increased the price objective on the shares of the company from a sum of $1,350 to $1,460, along with a rating overweight. This was then published in a research report on the 5th of November. New Street Research also gave the shares of MELI a rating of buy, along with a price target set at $1,450 on the 19th of October. Zacks Investment Research went the other way with a rating of hold from a previous rating of strong-buy, and a price target of $1,808. In the end, BTIG Research has also gone the same way, with a rating of the company shifted from buy to neutral.

The Quarterly Earnings Of MELI

The stocks of MELI traded on Friday at $1,965.05. The moving average price of the firm over a course of 50-days is $1,701.52, with the moving average price of the firm of 200 days being fixed at $1,313.02. The year low of the company is $422.22, while the year high of the company is $2,020. The company enjoys a 0.35 debt-to-equity ratio, along with a 1.64 current ratio. The market cap of the firm is $98 billion.

MELI did post its previous quarterly update on the 4th of November. The EPS reported by the company for that quarter was $0.28, which was more than the consensus sum of around $0.08.